Caffeic acid phenethyl ester (CAPE) possesses pro-hypoxia and anti-stress activities: bioinformatics and experimental evidences

[1]  S. Matsugo,et al.  3,4‐dihydroxybenzalacetone and caffeic acid phenethyl ester induce preconditioning ER stress and autophagy in SH‐SY5Y cells , 2018, Journal of cellular physiology.

[2]  Y. Padwad,et al.  HIF-1 in cancer therapy: two decade long story of a transcription factor , 2017, Acta oncologica.

[3]  K. Pantel,et al.  Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape , 2017, Nature Reviews Clinical Oncology.

[4]  H. Jane Dyson,et al.  Hypersensitive termination of the hypoxic response by a disordered protein switch , 2017, Nature.

[5]  S. Z. Abdel‐Rahman,et al.  Caffeic Acid Phenethyl Ester: A Review of Its Antioxidant Activity, Protective Effects against Ischemia-reperfusion Injury and Drug Adverse Reactions , 2016, Critical reviews in food science and nutrition.

[6]  S. Kaul,et al.  Molecular Characterization and Enhancement of Anticancer Activity of Caffeic Acid Phenethyl Ester by γ Cyclodextrin , 2016, Journal of Cancer.

[7]  Ashley I Bush,et al.  Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics , 2016, Journal of neurochemistry.

[8]  Michael H. Schwartz,et al.  Reversible, Specific, Active Aggregates of Endogenous Proteins Assemble upon Heat Stress , 2015, Cell.

[9]  Wei Li,et al.  HIF-1α pathway: role, regulation and intervention for cancer therapy , 2015, Acta pharmaceutica Sinica. B.

[10]  Won‐Kyo Jung,et al.  Caffeic acid phenethyl ester reduces the secretion of vascular endothelial growth factor through the inhibition of the ROS, PI3K and HIF-1α signaling pathways in human retinal pigment epithelial cells under hypoxic conditions. , 2015, International journal of molecular medicine.

[11]  G. Baldwin,et al.  HIF1α expression under normoxia in prostate cancer--which pathways to target? , 2015, The Journal of urology.

[12]  G. Murtaza,et al.  Caffeic Acid Phenethyl Ester and Therapeutic Potentials , 2014, BioMed research international.

[13]  Susan Lindquist,et al.  Mechanisms of protein-folding diseases at a glance , 2014, Disease Models & Mechanisms.

[14]  S. Z. Abdel‐Rahman,et al.  Caffeic acid phenethyl ester, a promising component of propolis with a plethora of biological activities: A review on its anti‐inflammatory, neuroprotective, hepatoprotective, and cardioprotective effects , 2013, IUBMB life.

[15]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[16]  H. Car,et al.  Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line , 2013, BMC Complementary and Alternative Medicine.

[17]  Clara Navarrete,et al.  Arsenite interferes with protein folding and triggers formation of protein aggregates in yeast , 2012, Journal of Cell Science.

[18]  Honglian Shi,et al.  Hypoxia inducible factor-1 as a target for neurodegenerative diseases. , 2011, Current medicinal chemistry.

[19]  A. Vollmar,et al.  Caffeic acid phenethyl ester inhibits PDGF-induced proliferation of vascular smooth muscle cells via activation of p38 MAPK, HIF-1α, and heme oxygenase-1. , 2011, Journal of natural products.

[20]  Daniel Gallichan,et al.  Neuroprotection by Dimethyloxalylglycine following Permanent and Transient Focal Cerebral Ischemia in Rats , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Bernd Bukau,et al.  Cellular strategies for controlling protein aggregation , 2010, Nature Reviews Molecular Cell Biology.

[22]  Yunjin Jung,et al.  Caffeic acid phenethyl ester is a potent inhibitor of HIF prolyl hydroxylase: structural analysis and pharmacological implication. , 2010, The Journal of nutritional biochemistry.

[23]  Giovanni Coppola,et al.  HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease. , 2010, Antioxidants & redox signaling.

[24]  R. Moreno-Sánchez,et al.  HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. , 2009, Mini reviews in medicinal chemistry.

[25]  U. Dirnagl,et al.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use , 2009, The Lancet Neurology.

[26]  Shanta M. Messerli,et al.  CAPE (caffeic acid phenethyl ester)‐based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice , 2009, Phytotherapy research : PTR.

[27]  W. Kaelin.  The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer , 2008, Nature Reviews Cancer.

[28]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[29]  L. Peso,et al.  Hypoxia-inducible factors and cancer , 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[30]  M. Simon,et al.  Hypoxia-inducible factors: central regulators of the tumor phenotype. , 2007, Current opinion in genetics & development.

[31]  Federico D. Sacerdoti,et al.  Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters , 2006, ACM/IEEE SC 2006 Conference (SC'06).

[32]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[33]  J. LaManna,et al.  Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition , 2005, Journal of Biological Chemistry.

[34]  D. Holtzman,et al.  Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. , 2004, Brain : a journal of neurology.

[35]  Peter Vaupel,et al.  The role of hypoxia-induced factors in tumor progression. , 2004, The oncologist.

[36]  M. Simon,et al.  Regulation of Transcription and Translation by Hypoxia , 2004, Cancer biology & therapy.

[37]  Kyu-Won Kim,et al.  Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions , 2004, Experimental & Molecular Medicine.

[38]  A. Goldberg,et al.  Protein degradation and protection against misfolded or damaged proteins , 2003, Nature.

[39]  C. Dobson.  Protein folding and misfolding , 2003, Nature.

[40]  A. Mackinnon,et al.  Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. , 2003, Archives of neurology.

[41]  B. Kurganov,et al.  Kinetics of heat- and acidification-induced aggregation of firefly luciferase. , 2003, Biophysical chemistry.

[42]  Kyu-Won Kim,et al.  Hypoxia-induced angiogenesis during carcinogenesis. , 2003, Journal of biochemistry and molecular biology.

[43]  J. Elkins,et al.  Structure of Factor-inhibiting Hypoxia-inducible Factor (HIF) Reveals Mechanism of Oxidative Modification of HIF-1α* , 2003, The Journal of Biological Chemistry.

[44]  J. Deisenhofer,et al.  Structure of factor-inhibiting hypoxia-inducible factor 1: An asparaginyl hydroxylase involved in the hypoxic response pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  P. Maffia,et al.  Phytochemical compounds involved in the anti-inflammatory effect of propolis extract. , 2002, Fitoterapia.

[46]  Dena Leshkowitz,et al.  Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in Apoptosis , 2002, Molecular and Cellular Biology.

[47]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[48]  L. Huang,et al.  Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway , 1998 .

[49]  G. Semenza,et al.  Structural and functional analysis of hypoxia-inducible factor 1. , 1997, Kidney international.

[50]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[51]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[52]  M. Morange,et al.  Protein denaturation during heat shock and related stress. Escherichia coli beta-galactosidase and Photinus pyralis luciferase inactivation in mouse cells. , 1989, The Journal of biological chemistry.

[53]  C. Moraes,et al.  Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments. , 2013, Advances in cancer research.

[54]  A. Uzun,et al.  Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[55]  M. Paintz,et al.  [On the antimicrobial activity of propolis and propolis constituents (author's transl)]. , 1979, Die Pharmazie.